期刊文献+

舒洛地特对大鼠脑缺血再灌注损伤后脑组织的保护作用及机制 被引量:6

Effects of sulodexide on focal cerebral ischemia and ischemia-reperfusion injury in rats
下载PDF
导出
摘要 目的探讨舒洛地特对大鼠脑缺血再灌注后脑组织的保护作用及机制。方法将72只Wistar大鼠随机分为3组即假手术组、模型组、舒洛地特干预组,采用改良Zea Longa[1]线栓法制备大鼠大脑中动脉局灶性脑缺血模型,应用免疫组化法检测肿瘤坏死因子-а(TNF-а)及C-反应蛋白(CRP)的表达。结果大鼠局灶性脑缺血再灌注后缺血脑组织中TNF-a及CRP含量增加(P<0.01)。与模型组相比较,舒洛地特组TNF-a及CRP的含量减少,脑组织肿胀减轻,死亡神经元明显减少,神经功能缺损评分降低(P<0.05)。结论舒洛地特对大鼠脑缺血再灌注损伤有一定的保护作用,其机制可能是多方面的。 ObjectiveTo investigate the neuroprotective effects and mechanism of sulodexide on focal cerebral ischemia and ischemia-reperfusion injury in rats.MethodsSeventy-two Wistar rats were randomly divided into three groups,sham-operative group,model group and sulodexide group.The model of middle cerebral artery occlusion(MCAO) was made by the method of modified Zea Longa.The expressions of TNF-α and CRP were detected by immunohistochemical analysis.ResultsThe expressions of TNF-α and CRP in the ischemic territory increased after cerebral ischemia(P0.01).Compared with the model group,the expression of TNF-α and CRP decreased in sulodexide group,the swelling of cerebral lightened,the number of death nerve cell decreased,and Longa's score reduced(P0.05).ConclusionSulodexide could protect the cerebral after focal cerebral ischemia,the mechanism is complicated.
出处 《中国实用神经疾病杂志》 2011年第3期30-32,共3页 Chinese Journal of Practical Nervous Diseases
关键词 脑缺血再灌注 舒洛地特 肿瘤坏死因子 C-反应蛋白 Ischemia-reperfusion injury Sulodexide TNF-α CRP
  • 相关文献

参考文献12

  • 1Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniotomy in rats[J].Stroke,1989,20(1):84-91.
  • 2Hawkins BT,Davis TP.The blood -brain barrier/neurovascular unit in health and disease[J].Pharmacol Rev,2005,57(2):173-185.
  • 3杨佳丹,董志.脑缺血再灌注损伤的病因学研究进展[J].中国康复医学杂志,2006,21(10):935-938. 被引量:21
  • 4Huang J,Upadhyay UM,Tamargo RJ.Inflammation in stroke and focal cerebral ischemia[J].Surg Neurol,2006,66(3):232-245.
  • 5Ohtaki H,Yin L,Nakamachi T et al.Expression of tumor necrosis factor alpha in nerver fibers and oligodendricytes after transient focal ischemia in mice[J].Neurosci Lett,2004,368:162-166.
  • 6Muri KW,Weir CJ,Awan W,et al.C-reactive protein and outcome after ischemic stroke[J].Stroke,2004,30(5):981-985.
  • 7Lavine SD,Hofman FM,Zlokovic BV.Circulation antibody against tumor necrosis factor-a protects rat brain from reperfusion injury[J].Cereb Blood Flow Metab,1998,18(1):52-58.
  • 8Lauver DA,Lucchesi BR.Sulodexide:A renewed interest in this Glycosaminoglycan[J].Lucchesi Cardiovascular Drug Reviews,2006,24,(3/4):214-226.
  • 9Miriam Barbanti,Stefano Guizzardi,Fiorella Calanni,et al.Anfithrombotic and thrombolytic activity of sulodexide in rats[J].Int J Clin Lab Res,1992,(22):179-184.
  • 10徐海平,郑红光.舒洛地特对糖尿病大鼠肾脏转化生子因子β1与结缔组织生长因子表达的影响[J].中国老年学杂志,2009,29(12):1498-1500. 被引量:4

二级参考文献25

  • 1董凤芹,李红,蔡卫民,陶君,李群,阮昱,郑芬萍,张哲.吡格列酮对糖尿病大鼠肾组织基质金属蛋白酶2和9表达的影响[J].中华内分泌代谢杂志,2004,20(5):459-460. 被引量:17
  • 2吴其标,曹世宏.中性粒细胞弹性蛋白酶在支气管扩张症发病中的作用及治疗对策[J].国外医学(内科学分册),2004,31(12):519-522. 被引量:14
  • 3Bates B,Hirt L,Thomas SS,et al.Neurotrophin-3 promotes cell death induced in cerebral ischemia,oxygen-glucose deprivation,and oxidative stress: possible involvement of oxygen free radicals[J]. Neurobiol Dis,2002,9(1):24- 37.
  • 4Chen YH,Du GH,Zhang JT. Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats [J]. Acta Pharmacol Sin, 2000,21 (5):463-466.
  • 5Pluta R. No effect of anti-oxidative therapy on cerebral amyloidosis following ischemia-reperfusion brain injury [J]. Folia Neuropathol, 2000,38(4):188- 190.
  • 6de la Monte SM,Neely TR,Cannon J,et al. Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons [J]. Cell Mol Life Sci ,2000,57(10):1471-1481.
  • 7Bosetti F,Yu GY,Zucchi R,et al. Myocardial ischemic precon-ditioning and mitochndrial F1F0-ATPase activity [J].Mol Cell Biochem, 20OO, 215(1-2):31- 37.
  • 8Levy J,Zhu Z,Dunbar JC. The effect of global brain ischemia in normal and diabetic animals: the influence of calcium channel blockers[J]. Endocrine,2004,25(2):91- 95.
  • 9Aoki T,Sumii T,Mori T,et al. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats[J]. Stroke,2002,33(11): 2711-2777.
  • 10Wu XD,Du LN,Wu GC,et al. Effects of electroacupuncture on blood-brain barrier after cerebral ischemia-reperfusion in rat[J]. Acupunct Electrother Res, 2001,26(1-2): 1-9.

共引文献23

同被引文献56

  • 1辛雅萍,张苏河,赵志刚,李青菊,田晨光,李鹏诺,付艳芹,李风良.2型糖尿病合并脑梗死患者血清脂联素水平测定及临床意义[J].中国实用神经疾病杂志,2006,9(4):61-62. 被引量:6
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33041
  • 3宋贵军,唐建武,尹琳,王乃昌,包礼平.依达拉奉对脑缺血-再灌注损伤大鼠的抗细胞凋亡与神经保护作用[J].医药导报,2007,26(6):582-585. 被引量:16
  • 4Lauver DA, Lucchesi BR. Sulodexide : a renewed interest in this glyco- saminoglycan[J]. Cardiovascu Drug Rev,2006,24(3/4):214-226.
  • 5徐海平,郑红光.舒洛地特对糖尿病大鼠肾脏转化生子因子p1与结缔组织生长因子表达的影响[J].中国老年医学杂志,2009,29(12):1498-1500.
  • 6Hansson GK.Inflammation,atherosclerosis,and coronary ar- tery disease[J].N ENGL J Med,2005,352(16):1685-1695.
  • 7Barlic J,Murphy PM.Chemokine regulation of atherosclerosis[J].J Leukoc Biol,2007,82(2):226-236.
  • 8Wilbanks A,Zondlo SC,Murphy K,et al.Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC,CXC,and CX3C chemokines[J].J Immunol,2001,166(8):5 145-5154.
  • 9Shimaoka T,Nakayama T,Fukumoto N,et al.Cell surface- anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells[J].J Leukoc Biol,2004,75(2):267-274.
  • 10Wuttge DM,Zhou X,Sheikine Y,et al.CXCLl6/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger recep- tor expressed in atherosclerotic lesions[J].Arterioscler Thromb Vasc Biol,2004,24(4):750-755,.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部